Jane Street’s Senti Biosciences Holdings SNTI Stock Holding History

Jane Street’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.8K	Buy	+52,530	New	+$51.4K	﹤0.01%	10869
2026 Q1	–	Sell	-38,427	Closed	-$40K	–	12901
2025 Q4	$40K	Buy	+38,427	New	+$67.9K	﹤0.01%	10568
2022 Q2	–	Sell	-30,009	Closed	-$2.96M	–	10782
2022 Q1	$2.96M	Sell	30,009 -1,045	-3%	-$103K	﹤0.01%	3986
2021 Q4	$3.06M	Buy	31,054 +781	+3%	+$77.9K	﹤0.01%	3649
2021 Q3	$3.01M	Buy	30,273 +270	+0.9%	+$26.6K	﹤0.01%	3649
2021 Q2	$2.98M	Buy	+30,003	New	+$2.99M	﹤0.01%	3581

Other funds holding SNTI

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MVM

Menlo Ventures Management Menlo Park, California $357M AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street's SNTI Position: Q2 2026 in Review

Jane Street opened a new position in Senti Biosciences Holdings (SNTI) in Q2 2026: 52,530 shares worth $57.8K. The stake represents ﹤0.01% of the portfolio and ranks #10869 among its holdings. This is a return to the name: Jane Street previously reported a position in SNTI as recently as Q4 2025.

Jane Street first reported a position in SNTI in Q2 2021 and has held it in 6 quarters since. The position peaked at $3.06M in Q4 2021. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

Jane Street held 52,530 shares of Senti Biosciences Holdings worth $57.8K as of Q2 2026.
Senti Biosciences Holdings was a new Jane Street position in Q2 2026.
Senti Biosciences Holdings made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10869 holding.
Jane Street first reported a position in Senti Biosciences Holdings in Q2 2021 and has held it in 6 quarters since.
Jane Street's Senti Biosciences Holdings position peaked at $3.06M in Q4 2021.
19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.